March 29 (Reuters) - Milestone Pharmaceuticals Inc MIST.O :
* MILESTONE PHARMACEUTICALS ANNOUNCES FIRST PATIENT ENROLLED IN THE REVERA STUDY, ITS PHASE 2 TRIAL OF ETRIPAMIL IN ATRIAL FIBRILLATION AND RAPID VENTRICULAR RATE
March 29 (Reuters) - Milestone Pharmaceuticals Inc MIST.O :
* MILESTONE PHARMACEUTICALS ANNOUNCES FIRST PATIENT ENROLLED IN THE REVERA STUDY, ITS PHASE 2 TRIAL OF ETRIPAMIL IN ATRIAL FIBRILLATION AND RAPID VENTRICULAR RATE